ORPHA:91492
Early onset non-syndromic cataract
Query health: suspect — Only one of 2 strategies returned hits (recall-expansion).
Publications
0
Trials
8
Interventional, condition-specific
Researchers
0
Distinct authors in sample
Gene link
BFSP2, CRYBB3, EPHA2
Moderate
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, non-syndromic developmental defect of the eye disorder, with high clinical and genetic heterogeneity, most frequently characterized by bilateral, symmetrical, non- cataracts which present at birth or in early-childhood. Additional ocular manifestations (e.g. anterior segment dysgenesis, colobomas, nystagmus, microcornea, microphthalmia, myopia) may be associated, however other organs/systems are usually not affected.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0011060
- OMIM:601371
- UMLS:C1832423
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Moderate — BFSP2, CRYBB3, EPHA2
- LiteratureNot found
No matched Europe PMC hits under our query rules Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
8 matched on ClinicalTrials.gov (3 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Probably — there is moderate evidence for BFSP2, CRYBB3, EPHA2.
GenCC classification: Moderate.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
0
We found no papers under this exact name — work may still exist under another label.
0 in the last 10 years · low confidence
Phrase hits: 0 · MeSH hits: 0
Who's working on it?
0
Distinct author names in 0 sampled papers.
Who's working on it?
No author names could be extracted from the sampled publications. Try the Europe PMC query in “How we counted this,” or contact an umbrella rare-disease organisation for researcher referrals.
Clinical research
Is a treatment being tested?
8
interventional trials for this specific condition
8 interventional trials matched this specific condition name; 3 currently recruiting in our sample. 1,236 trials are registered for cataract, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
8 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 90.6th percentile).
low confidence · 90.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
8 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT05631886·RECRUITING·Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
Conditions: Solid Tumor, Adult · Lymphoma · EphA2 Overexpression · TP53 R273H·Matched via recall expansion
- NCT06972576·RECRUITING·Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer·Matched via recall expansion
- NCT06186401·RECRUITING·Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
Conditions: EGFR Gene Mutation · Glioblastoma · MGMT-Unmethylated Glioblastoma · Recurrent Glioblastoma·Matched via recall expansion
Broader category: cataract
1,236
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07471295·RECRUITING·Toric Performance And Constant Evaluation
Conditions: Cataract·Matched via name phrase
- NCT06754358·RECRUITING·Clinical Application Comparison of Two Femtosecond Laser Systems
Conditions: Cataract·Matched via name phrase
- NCT06624826·RECRUITING·Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality
Conditions: Cataract·Matched via name phrase
- NCT05694858·RECRUITING·Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting
Conditions: Glaucoma · Cataract · Ophthalmological Disorder·Matched via name phrase
- NCT06500416·NOT YET RECRUITING·Visual Outcomes of Tecnis Symfony Opti-Blue EDOF Intraocular Lens (IOL)
Conditions: Cataract·Matched via name phrase
- NCT07623317·NOT YET RECRUITING·Can Tailored Surgical Incisions Reduce Refractive Error and Dependence on Glasses After Cataract Surgery?
Conditions: Cataract (Post-operative Cataract Surgery Follow-up) · Refraction Error·Matched via name phrase
- NCT06760169·RECRUITING·Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery
Conditions: Glaucoma·Matched via name phrase
- NCT06600932·NOT YET RECRUITING·Evaluation of TMS Visual Outcome
Conditions: Cataract Surgery Experience·Matched via name phrase
- NCT07223866·NOT YET RECRUITING·The Impact of Physiologic Cataract Surgery on Patient Comfort and Medication Usage
Conditions: Cataract and IOL Surgery · Cataract Surgery Anesthesia · Cataract Surgery Experience · Nuclear Cataract·Matched via name phrase
- NCT02678962·RECRUITING·Comparison of Outcomes With Multifocal Intraocular Lenses
Conditions: Cataract·Matched via name phrase
- NCT07407049·NOT YET RECRUITING·Comparison of Early Postoperative Visual Acuity Between Intracapsular and Supracapsular Phacoemulsification: A Randomized Controlled Clinical Trial
Conditions: Cataract·Matched via name phrase
- NCT07397949·NOT YET RECRUITING·Rebamipide Versus Diquafosol for Perioperative Dry Eye in Cataract Surgery
Conditions: Dry Eye Disease (DED) · Cataract·Matched via name phrase
- NCT06658119·RECRUITING·Clinical Evaluation of Extended Depth-of-focus Intraocular Lens in Refractive Cataract Surgery: a Randomized Controlled Trial
Conditions: Cataract·Matched via name phrase
- NCT07155057·RECRUITING·Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery
Conditions: Dry Eye Disease (DED)·Matched via name phrase
- NCT07036510·RECRUITING·Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
Conditions: Glaucoma · Ocular Hypertension·Matched via name phrase
Observational and natural-history studies
2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07593209·RECRUITING·First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2
Conditions: Malignant Tumor·Matched via recall expansion
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Early onset non-syndromic cataract"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Early onset non-syndromic cataract" OR "BFSP2" OR "CRYBB3" OR "EPHA2"
Recall-expansion terms: BFSP2, CRYBB3, EPHA2
Interventional trials matched via: recall-expansion (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 8 interventional · 2 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"cataract"
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: recall-expansion
Parent literature probe: cataract (MONDO:0005129) — 197446 hits
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Zero publications but parent term cataract has 197446 — literature likely indexed under a broader name
Ingested 2026-07-27T04:03:50.385Z · excluded from neglect metrics
